CMND stock icon

Clearmind Medicine


About: Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Employees: 4

Funds holding %
of 6,689 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

300% more funds holding

Funds holding: 1 [Q4 2023] → 4 (+3) [Q1 2024]

0.64% less ownership

Funds ownership: 5.48% [Q4 2023] → 4.84% (-0.64%) [Q1 2024]

33% less capital invested

Capital invested by funds: $260K [Q4 2023] → $175K (-$85.2K) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for CMND.

Financial journalist opinion